What's really going on

You don't have a volume problem. You have an ownership problem. Emails, walk-ins, web forms and LinkedIn all land in different inboxes, and nobody knows who owns the optician in Cork or the clinic in Austin until someone chases twice. With 10+ people touching 500+ inquiries, two reps are quietly working the same account while a third account goes cold for a month. That's the leak — not the tools.

What to do instead

1. HubSpot Free CRM (free, unlimited users) — one shared pipeline with clear owner, stage and next step per account. Fits your team size and inbound-heavy mix across UK, Ireland and US.
2. Web form + LinkedIn → HubSpot — pipe the web form straight in, and log LinkedIn conversations as a contact note the same day. Kills the "who's talking to them" question.
3. Habit: a 15-minute Monday pipeline stand-up — every rep names their top 5 accounts and the next action. No tool replaces this.

First action, today: in HubSpot, create three pipelines — UK/Ireland Hospitals & Pharmacies, UK/Ireland Opticians, US Private Clinics. Add stages: New → Qualified → Sampling → Ordering → Won. Import last month's inquiries. One hour, one person.

What you're being oversold

Someone will push you toward Salesforce or HubSpot Sales Hub Enterprise because you're "multi-region, regulated, medical." At your stage that's a six-month implementation for features you won't touch. Cliniko is for clinics running bookings — you sell to clinics, you're not one, so it's the wrong shape. Doing nothing costs you the accounts nobody remembers to follow up with — in a repeat-order business like eye drops, a lost optician is lost reorders for years, not one deal.

When to revisit this

When two reps hit the same account in the same week, or when HubSpot's free reporting can't answer "what's our US pipeline worth this quarter" — then look at paid Sales Hub, not before.

The part worth getting right

The one call is whether the US clinic business runs on the same pipeline as UK/Ireland wholesale, or its own. They look similar. They aren't. UK/Ireland is long procurement cycles into pharmacy chains and NHS-adjacent buyers, with slow, formal stages. US private clinics are faster, founder-led, sample-and-reorder. Put them on one pipeline and your stages will fit neither — reps will force-fit deals and your forecast will lie. Split them and you double the setup but each pipeline reflects how that market actually buys. Which side you're really scaling into next decides it.